HighTide Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
HighTide Therapeutics has a total shareholder equity of CN¥548.7M and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥621.8M and CN¥73.1M respectively.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥563.44m |
| Equity | CN¥548.66m |
| Total liabilities | CN¥73.11m |
| Total assets | CN¥621.77m |
Financial Position Analysis
Short Term Liabilities: 2511's short term assets (CN¥594.4M) exceed its short term liabilities (CN¥54.6M).
Long Term Liabilities: 2511's short term assets (CN¥594.4M) exceed its long term liabilities (CN¥18.5M).
Debt to Equity History and Analysis
Debt Level: 2511 is debt free.
Reducing Debt: 2511 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2511 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 2511 has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 49.9% each year.